Extendicare (TSE:EXE) Raised to “Hold” at BMO Capital Markets

Extendicare (TSE:EXEGet Free Report) was upgraded by investment analysts at BMO Capital Markets to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

EXE has been the subject of a number of other reports. Royal Bank of Canada boosted their price objective on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. TD Securities boosted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday, November 14th.

Check Out Our Latest Stock Analysis on Extendicare

Extendicare Trading Down 0.2 %

Shares of EXE stock opened at C$10.35 on Tuesday. Extendicare has a fifty-two week low of C$6.63 and a fifty-two week high of C$10.89. The company has a 50 day moving average price of C$10.36 and a 200 day moving average price of C$9.18. The stock has a market capitalization of C$863.91 million, a P/E ratio of 15.22 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60.

Extendicare (TSE:EXEGet Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported C$0.19 EPS for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same period in the prior year, the business earned $0.13 earnings per share. Equities research analysts predict that Extendicare will post 0.6134729 EPS for the current fiscal year.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Articles

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.